Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,141.97
860.65
715.91
647.69
493.59
415.59
350.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,141.97
860.65
715.91
647.69
493.59
415.59
350.87
Raw Material Cost
774.81
591.73
499.74
477.65
341.72
267.03
239.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
81.30
59.58
49.43
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.92
2.43
0.20
1.18
4.38
2.50
4.57
Selling and Distribution Expenses
66.94
46.40
46.88
40.22
32.10
43.79
30.94
Other Expenses
-4.35
-3.30
-2.61
1.86
0.75
0.92
0.40
Total Expenditure (Excl Depreciation)
882.52
667.12
570.16
537.66
385.74
322.53
278.77
Operating Profit (PBDIT) excl Other Income
259.5
193.5
145.8
110
107.89999999999999
93.10000000000001
72.1
Other Income
28.29
27.82
27.61
8.35
7.10
6.23
5.51
Operating Profit (PBDIT)
366.88
268.72
222.00
166.10
157.73
131.18
105.34
Interest
2.92
2.43
0.20
1.18
4.38
2.50
4.57
Exceptional Items
1.27
2.70
0.00
1.62
0.00
0.00
2.82
Gross Profit (PBDT)
367.17
268.92
216.17
170.04
151.87
148.55
111.59
Depreciation
79.92
47.47
48.72
47.77
43.27
32.58
27.89
Profit Before Tax
285.31
221.52
173.09
118.77
110.09
96.10
75.70
Tax
39.71
28.52
22.34
14.29
14.54
13.31
10.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
245.60
193.00
150.75
104.48
95.55
82.78
65.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
245.60
193.00
150.75
104.48
95.55
82.78
65.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
245.60
193.00
150.75
104.48
95.55
82.78
65.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,679.24
1,507.83
1,344.95
1,203.46
691.09
597.07
501.71
Earnings per share (EPS)
0.58
0.46
0.36
0.25
0.23
0.2
0.16
Diluted Earnings per share
0.58
0.46
0.36
0.25
0.23
0.2
0.16
Operating Profit Margin (Excl OI)
22.65%
22.47%
20.35%
16.98%
21.75%
22.23%
20.5%
Gross Profit Margin
31.98%
31.25%
30.98%
25.71%
31.07%
30.96%
29.52%
PAT Margin
21.51%
22.42%
21.06%
16.13%
19.36%
19.92%
18.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 32.70% vs 20.21% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 27.25% vs 27.98% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 40.56% vs 23.92% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 20.83% vs 1,100.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,141.97
0
1,141.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,141.97
0
1,141.97
Raw Material Cost
774.81
0
774.81
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
81.30
0
81.30
Power Cost
0
0
0.00
Manufacturing Expenses
2.92
0
2.92
Selling and Distribution Expenses
66.94
0
66.94
Other Expenses
-4.35
0.00
-4.35
Total Expenditure (Excl Depreciation)
882.52
0
882.52
Operating Profit (PBDIT) excl Other Income
259.45
0.00
259.45
Other Income
28.29
0
28.29
Operating Profit (PBDIT)
366.88
0
366.88
Interest
2.92
0
2.92
Exceptional Items
1.27
0
1.27
Gross Profit (PBDT)
367.17
0
367.17
Depreciation
79.92
0
79.92
Profit Before Tax
285.31
0
285.31
Tax
39.71
0
39.71
Provisions and contingencies
0
0
0.00
Profit After Tax
245.60
0
245.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
245.60
0
245.60
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
245.60
0
245.60
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,679.24
0
1,679.24
Earnings per share (EPS)
0.58
0
0.58
Diluted Earnings per share
0.58
0
0.58
Operating Profit Margin (Excl OI)
22.65%
0%
0.00
22.65%
Gross Profit Margin
31.98%
0%
0.00
31.98%
PAT Margin
21.51%
0%
0.00
21.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 114.20 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 32.70% vs 20.21% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 24.56 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.25% vs 27.98% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.86 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.56% vs 23.92% in Dec 2023
Annual - Interest
Interest 0.29 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 20.83% vs 1,100.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.65%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






